Immediate Impact
27 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Hyung Jun Kwon being referenced
Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Hyung Jun Kwon | 140 | 113 | 94 | 33 | 240 | |
| José Fernandes Pontes | 94 | 55 | 83 | 33 | 288 | |
| Andrea Tufo | 158 | 180 | 127 | 20 | 299 | |
| Hironobu Suto | 169 | 199 | 108 | 41 | 273 | |
| Tomokazu Fuji | 170 | 105 | 66 | 55 | 291 | |
| Gianluca Mascianà | 167 | 82 | 97 | 28 | 255 | |
| Chimaobi M. Anugwom | 98 | 83 | 35 | 35 | 266 | |
| Alberto Oldani | 177 | 94 | 60 | 39 | 283 | |
| Jang Yong Jeon | 165 | 115 | 142 | 22 | 234 | |
| Koon Hee Han | 138 | 57 | 90 | 35 | 280 | |
| Naoyuki Katada | 181 | 84 | 51 | 28 | 290 |
All Works
Loading papers...